Research

Study of Immune Deficiency Diseases in Paediatrics (GEMDIP)

Search publications

Publications

  • Luo Y, Acevedo D, Baños-Lopez N, Pluma A, Castellanos-Moreira R, Moreno E, Rodríguez-García S, Deyà-Martinez A, García-García AP, Quesada-Masachs E, Torres M, Casellas M, Grados D, Martí-Castellote C, Anton-Lopez J, Vlagea A, Juan-Otero M, Esteve-Solé A and Alsina L.

    Expected impact of immunomodulatory agents during pregnancy: A newborn's perspective

    PEDIATRIC ALLERGY AND IMMUNOLOGY . 34(2): . Number of citations: 7

    [doi:10.1111/pai.13911]

  • García-García AP, Fortuny-Guasch C, Fumadó V, Jordán-García I, Ruiz-López L, González-Navarro EA, Egri N, Esteve-Solé A, Luo Y, Vlagea A, Manuel Monsonis Cabedo, Launes-Montana C, Soler-García a, Codina-Bergadà A, Juan-Otero M, Pascal-Capdevila R, Deyà-Martinez A and Alsina L.

    Acute and long-term immune responses to SARS-CoV-2 infection in unvaccinated children and young adults with inborn errors of immunity

    FRONTIERS IN IMMUNOLOGY . 14: 1084630-1084630. Number of citations: 2

    [doi:10.3389/fimmu.2023.1084630]

  • Murias, S, Boteanu, A, Calvo, I, Nunez, E, Bravo, B, Bustabad, S, Camacho, M, Clemente, D, Grana, J, de Inocencio, J, Lacruz, L, Mesa-del-Castillo, P, Nieto-Gonzalez, JC, Pinedo, MD, Quesada, E, Vargas, C and Anton-Lopez J.

    What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

    Reumatologia clinica . 19(1): 26-33. Number of citations: 1

    [doi:10.1016/j.reuma.2021.12.003]

  • Murias S, Boteanu A, Calvo I, Nuñez E, Bravo B, Bustabad S, Camacho M, Clemente D, Graña J, de Inocencio J, Lacruz L, Mesa-Del-Castillo P, Nieto-González JC, Pinedo MDC, Quesada E, Vargas C and Anton-Lopez J.

    What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment.

    reumatologia clinica . 19(1): 26-33.

    [doi:10.1016/j.reumae.2022.11.002]

  • Calzada-Hernández J, Anton-Lopez J, Martín-de-Carpi J, López-Montesinos B, Calvo I, Donat E, Núñez E, Blasco Alonso J, Mellado MJ, Baquero-Artigao F, Leis R, Vegas-Álvarez AM, Medrano San Ildefonso M, Pinedo-Gago MDC, Eizaguirre FJ, Tagarro A, Camacho-Lovillo M, Pérez-Gorricho B, Gavilán-Martín C, Guillén S, Sevilla-Pérez B, Peña-Quintana L, Mesa-Del-Castillo P, Fortuny-Guasch C, Tebruegge M and Noguera-Julián A.

    Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-a inhibitor initiation in children in Spain

    EUROPEAN JOURNAL OF PEDIATRICS . 182(1): 307-317. Number of citations: 10

    [doi:10.1007/s00431-022-04640-3]

  • Israni M, Nicholson B, Mahlaoui N, Obici L, Rossi-Semerano L, Lachmann H, Hayward G, Avramovic MZ, Guffroy A, Dalm V, Rimmer R, Solis L, Villar C, Gennery AR, Skeffington S, Nordin J, Warnatz K, Korganow AS, Anton-Lopez J, Cattalini M, Amin T, Berg S, Soler-Palacin P, Burns SO and Campbell M.

    Current Transition Practice for Primary Immunodeficiencies and Autoinflammatory Diseases in Europe: a RITA-ERN Survey.

    JOURNAL OF CLINICAL IMMUNOLOGY . 43(1): 206-216. Number of citations: 12

    [doi:10.1007/s10875-022-01345-y]

  • Margarit-Soler A, Deyà-Martinez A, Canizales JT, Vlagea A, García-García AP, Marsal-Ricoma J, Del Castillo MT, Planas-Roman S, Simó-Nebot S, Esteve-Solé A, Grande MS, Badell-Serra I, Tarrats MR, Fernández-Avilés F and Alsina L.

    Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders

    FRONTIERS IN IMMUNOLOGY . 13: 1070068-1070068. Number of citations: 4

    [doi:10.3389/fimmu.2022.1070068]

  • Krausz M, Uhlmann A, Rump IC, Ihorst G, Goldacker S, Sogkas G, Posadas-Cantera S, Schmidt R, Feißt M, Alsina L, Dybedal I, Recher M, Warnatz K and Grimbacher B.

    The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial

    Contemporary Clinical Trials Communications . 30: 101008-101008. Number of citations: 12

    [doi:10.1016/j.conctc.2022.101008]

  • Grasa CD, Fernández-Cooke E, Domínguez-Rodríguez S, Aracil-Santos J, Barrios Tascon A, Sánchez-Manubens J, Mercader B, Anton-Lopez J, Nuñez E, Villalobos E, Bustillo M, Camacho M, Oltra Benavent M, Giralt G, Bello Naranjo AM, Rocandio B and Calvo C.

    Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    CLINICAL RHEUMATOLOGY . 41(12): 3759-3768. Number of citations: 3

    [doi:10.1007/s10067-022-06319-4]

  • Morán-Álvarez P, Andreu-Suárez Á, Caballero-Mota L, Gassiot S, Berrueco R, Calzada-Hernández J, Anton-Lopez J, Vázquez-Díaz M and Boteanu A.

    Non-criteria manifestations in the presence of antiphospholipid antibodies in a paediatric cohort

    RHEUMATOLOGY . 61(11): 4465-4471.

    [doi:10.1093/rheumatology/keac070]